Home > Insider Trading > Filing (0001649094-24-000105)

Filing Details

Accession Number:: 0001649094-24-000105
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-11-08 20:46:22
Reporting Period:: 2024-11-07

Accepted Time:: 2024-11-08 20:46:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649094	Vaxcyte Inc.	PCVX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1258693	Grant Pickering	C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-11-07	227	$102.68	138,354	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	463	$103.43	137,891	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	377	$104.71	137,514	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	116	$105.50	137,398	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	281	$102.64	138,300	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	363	$103.36	137,937	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	434	$104.72	137,503	No	4	S	Indirect	By Children's Trust
Common Stock	Disposition	2024-11-07	105	$105.50	137,398	No	4	S	Indirect	By Children's Trust
Common Stock	Acquisiton	2024-11-07	663	$0.04	435,882	No	4	M	Direct
Common Stock	Acquisiton	2024-11-07	14,129	$2.03	450,011	No	4	M	Direct
Common Stock	Acquisiton	2024-11-07	16,000	$5.35	466,011	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	S	Indirect	By Children's Trust
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-11-07	663	$0.00	663	$0.04
Common Stock	Stock Option (right to buy)	Disposition	2024-11-07	14,129	$0.00	14,129	$2.03
Common Stock	Stock Option (right to buy)	Disposition	2024-11-07	16,000	$0.00	16,000	$5.35
Common Stock	Performance Stock Option (right to buy)	Acquisiton	2024-11-07	197,784	$0.00	197,784	$102.70
Common Stock	Performance Restricted Stock Units	Acquisiton	2024-11-07	80,625	$0.00	80,625	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2025-04-23	No	4	M	Direct
153,198	2028-07-23	No	4	M	Direct
202,717	2030-04-17	No	4	M	Direct
197,784	2034-11-06	No	4	A	Direct
80,625	2034-11-06	No	4	A	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024.
The price reported is a weighted-average price. The shares were sold at prices ranging from $102.19 to $103.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
The price reported is a weighted-average price. The shares were sold at prices ranging from $103.28 to $104.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $104.405 to $105.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $102.09 to $103.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's son.
Stock Option is fully vested and exercisable.
As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the "Grant Date"), the Reporting Person was granted a performance stock option to purchase 197,784 shares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth and fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price)).
Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units ("PSUs"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return ("TSR") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares.